Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease

Journal of Immunology

Volumn 167, Issue 10, 2001, Pages 5904-5912

  O'Brien, N C ^a   Charlton, B ^a   Cowden, W B ^a   Willenborg, D O ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; N(G) METHYLARGININE; N(G) METHYLARGININE ACETATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE; SECONDARY IMMUNE RESPONSE;

EID: 0035889960     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.10.5904     Document Type: Article

References (36)

1. Nitric oxide: Biosynthesis and biological significance
2. Nitric oxide: Physiology, pathophysiology and pharmacology
3. Nitric oxide, a novel biologic messenger
4. Targeted disruption of the neuronal nitric oxide synthase gene
5. Nitric oxide: An endogenous modulator of leukocyte adhesion
6. Nitric oxide synthase: Expression and expressional control of the three isoforms
7. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo
8. Role of nitric oxide synthesis in macrophage antimicrobial activity
9. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
10. Biology of disease: The analysis of autoimmune demyelination: Its impact on multiple sclerosis
11. Astrocytic hypertrophy: An important pathological feature of chronic experimental autoimmune encephalomyelitis in aged rats
12. Neuropathology of experimental allergic encephalomyelitis
13. Approaches to the treatment of central nervous system autoimmune disease using specific neuroantigen
14. Regulation of paralytic experimental allergic encephalomyelitis in rats: Susceptibility to active and passive disease reinduction
15. Experimental allergic encephalomyelitis in the Lewis rat: Studies on the mechanism of recovery from disease and acquired resistance to reinduction
16. Mechanisms of recovery and acquired resistance in the Lewis rat experimental allergic encephalomyelitis
17. Nitric oxide is a potential down-regulating molecule in autoimmune disease: Inhibition of nitric oxide production renders PVG rats highly susceptible to EAE
18. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction
19. Suppression of the immune response: Reversal of the disease state with antigen in allergic encephalomyelitis
20. Possible role of nitric oxide in malarial immunosuppression
21. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages
22. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat
23. Cyclosporin inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human lymphocytes by altering expression of the class II transcriptional activator gene
24. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats
25. Non-pseudomonal malignant otitis extema and juglar foramen syndrome secondary to cyclosporin-induced hypertrichosis in a diabetic renal transplant patient
26. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord in incomplete Freund's adjuvant
27. The fate of neonatally injected effector cells of allergic encephalomyelitis
28. Inhibition of macrophage Ia expression by nitric oxide
29. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway
30. Nitric oxide suppresses human T lymphocyte proliferation throught IFN-γ-dependent and IFN-γ-independent induction of apoptosis
31. Nitric oxide and thiol redox regulation of Janus kinase activity
32. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis
33. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors
34. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
35. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation
36. A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis